# Talis Biomedical Corp

Talis Biomedical Corp is a company headquartered in Chicago, IL, United States.

## Company overview

- **Legal name:** Talis Biomedical Corp
- **Former names in filing history:** SlipChip Corp (2013-08-20 to 2017-10-17)
- **Classification:** Company
- **Industry (SIC):** 3826 — Laboratory Analytical Instruments
- **Headquarters:** Chicago, IL, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001584751

## About

Talis Biomedical Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001584751, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2024-03-28, it reported annual revenue of USD 2,134,000; net income of USD -62,007,000; total assets of USD 94,674,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2023 (period ended 2023-12-31)

- **Revenue:** $2.1M (USD 2,134,000)
- **Net income:** -$62.0M (USD -62,007,000)
- **Total assets:** $94.7M (USD 94,674,000)
- **Cash and equivalents:** $76.7M (USD 76,732,000)
- **Operating cash flow:** -$53.2M (USD -53,240,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $4.8M (USD 4,812,000)
- **Net income:** -$113.0M (USD -113,012,000)
- **Total assets:** $169.3M (USD 169,290,000)
- **Cash and equivalents:** $130.2M (USD 130,191,000)
- **Operating cash flow:** -$100.1M (USD -100,136,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$192.0M (USD -192,036,000)
- **Total assets:** $265.8M (USD 265,828,000)
- **Cash and equivalents:** $232.5M (USD 232,545,000)
- **Operating cash flow:** -$171.4M (USD -171,384,000)

## Recent SEC filings

- Form 8-K — filed 2024-09-17 — period 2024-09-16 — 8-K
- Form 8-K — filed 2024-09-06 — period 2024-08-30 — 8-K
- Form 8-K — filed 2024-09-03 — period 2024-08-29 — 8-K
- Form 8-K — filed 2024-08-23 — period 2024-08-22 — 8-K
- Form 10-Q — filed 2024-08-19 — period 2024-06-30 — 10-Q
- Form SC 13G — filed 2024-08-14
- Form 8-K — filed 2024-08-06 — period 2024-07-31 — 8-K
- Form 8-K — filed 2024-06-25 — period 2024-06-24 — 8-K
- Form 8-K — filed 2024-06-03 — period 2024-05-30 — 8-K
- Form 10-Q — filed 2024-05-08 — period 2024-03-31 — 10-Q
- Form 8-K — filed 2024-05-03 — period 2024-04-29 — 8-K
- Form 8-K — filed 2024-04-11 — period 2024-04-10 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/talis-biomedical-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
